Arkolith/Insider Trading/NVCR/Form 4

Brackmann Christoph

Chief Financial OfficerNovoCure Ltd (NVCR) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$85K
Net Open-Market Flow
-$85K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)6K$13.31$85K183K
Mar 3, 2026Grant(A)55K—$0189K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)81K—$081K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002048634-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML